Retatrutide
Retatrutide is an experimental once-weekly drug for obesity and type 2 diabetes. It acts on three gut and metabolic receptors at once (GLP-1, GIP and glucagon), which lowers appetite and helps the body burn more energy.
What it is studied for
Triple agonist
Hits GLP-1, GIP and glucagon receptors together
Appetite
Reduces hunger and food intake
Fat loss
Studied for significant body-weight reduction
Blood sugar
Researched for improved glucose control
Available at Bionova
View in shop →Research use only
This page is educational and describes what a compound is and how it is studied. It is not medical advice and makes no health claims. All products are sold strictly as research formulations for laboratory and in-vitro study — not for human or veterinary consumption, and not evaluated for the diagnosis, treatment, cure or prevention of any condition.